| Mr Roderick Nisi, MD | |
|
1601 Medical Arts Blvd, Suite 102, Anderson, IN 46011-3458 | |
| (765) 298-4720 | |
| (765) 298-4958 |
| Full Name | Mr Roderick Nisi |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 38 Years |
| Location | 1601 Medical Arts Blvd, Anderson, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821179714 | NPI | - | NPPES |
| 64042377 | Medicaid | KY | |
| P01512511 | Other | IN | MEDICARE RR |
| 10004427 | Other | IN | TCARE |
| 100176670B | Medicaid | IN | |
| 100009521 | Other | IN | RAILROAD MEDICARE |
| 100176670 | Medicaid | IN | |
| 000000085348 | Other | IN | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 01036283 (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Hospital Of Anderson And Madison County | Anderson, IN | Hospital |
| Community Hospital North | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Physicians Of Indiana Inc | 1759416662 | 1319 |
News Archive
Data presented today at The International Liver Congress 2015 demonstrates that remogliflozin etabonate, an investigational drug in type 2 diabetes, is a potential treatment option for the management of patients with non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD).
Patients who are taken to a level 2 trauma center after suffering serious injury are significantly more likely to die than comparable patients treated at a major level 1 trauma center, according to researchers at the Keck School of Medicine of the University of Southern California.
In an effort to continue to protect Michigan's seniors and vulnerable citizens without drug insurance coverage, Attorney General Mike Cox is pushing for disclosure of the prices of the most commonly-used prescription drugs over the Internet to increase consumer awareness and assist buyers with informed choices.
Disease-modifying drugs (DMDs) are injected medications used to slow the progression of multiple sclerosis, and have been shown to reduce the frequency and severity of relapses. But according to a new study led by St. Michael's Hospital and the Institute for Clinical Evaluative Sciences, adherence to all DMDs is low, with less than half of patients, or 44 per cent, continually adherent after two years.
› Verified 4 days ago
| Entity Name | Community Physicians Of Indiana Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619105244 PECOS PAC ID: 1759416662 Enrollment ID: O20100317000717 |
News Archive
Data presented today at The International Liver Congress 2015 demonstrates that remogliflozin etabonate, an investigational drug in type 2 diabetes, is a potential treatment option for the management of patients with non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD).
Patients who are taken to a level 2 trauma center after suffering serious injury are significantly more likely to die than comparable patients treated at a major level 1 trauma center, according to researchers at the Keck School of Medicine of the University of Southern California.
In an effort to continue to protect Michigan's seniors and vulnerable citizens without drug insurance coverage, Attorney General Mike Cox is pushing for disclosure of the prices of the most commonly-used prescription drugs over the Internet to increase consumer awareness and assist buyers with informed choices.
Disease-modifying drugs (DMDs) are injected medications used to slow the progression of multiple sclerosis, and have been shown to reduce the frequency and severity of relapses. But according to a new study led by St. Michael's Hospital and the Institute for Clinical Evaluative Sciences, adherence to all DMDs is low, with less than half of patients, or 44 per cent, continually adherent after two years.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Roderick Nisi, MD 6626 E 75th St, Ste 500, Indianapolis, IN 46250-2805 Ph: () - | Mr Roderick Nisi, MD 1601 Medical Arts Blvd, Suite 102, Anderson, IN 46011-3458 Ph: (765) 298-4720 |
News Archive
Data presented today at The International Liver Congress 2015 demonstrates that remogliflozin etabonate, an investigational drug in type 2 diabetes, is a potential treatment option for the management of patients with non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD).
Patients who are taken to a level 2 trauma center after suffering serious injury are significantly more likely to die than comparable patients treated at a major level 1 trauma center, according to researchers at the Keck School of Medicine of the University of Southern California.
In an effort to continue to protect Michigan's seniors and vulnerable citizens without drug insurance coverage, Attorney General Mike Cox is pushing for disclosure of the prices of the most commonly-used prescription drugs over the Internet to increase consumer awareness and assist buyers with informed choices.
Disease-modifying drugs (DMDs) are injected medications used to slow the progression of multiple sclerosis, and have been shown to reduce the frequency and severity of relapses. But according to a new study led by St. Michael's Hospital and the Institute for Clinical Evaluative Sciences, adherence to all DMDs is low, with less than half of patients, or 44 per cent, continually adherent after two years.
› Verified 4 days ago
Mark Randall Jennings, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2015 Jackson St, Anderson, IN 46016 Phone: 765-649-2511 | |
Dr. Dalwinderpal Singh Samra, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1547 Ohio Ave., Anderson, IN 46016 Phone: 609-694-8566 | |
Ubaidullah Sharief, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2020 Meridian St Ste 100, Anderson, IN 46016 Phone: 765-646-8509 | |
Adam L Greene, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 109, Anderson, IN 46016 Phone: 765-646-8538 | |
Chad Michael Feldman, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 109, Anderson, IN 46016 Phone: 765-646-8538 | |
Dr. Edgardo Manuel Flores Anticona, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St Ste 110, Anderson, IN 46016 Phone: 765-643-6012 Fax: 765-646-9054 | |
Kristine M Rea, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 212, Anderson, IN 46016 Phone: 765-648-4138 |